[
  {
    "patient_id": "PATIENT_355BF81D",
    "drug": "Warfarin",
    "timestamp": "2026-02-19T16:51:46.711577",
    "risk_assessment": {
      "risk_label": "Unknown",
      "confidence_score": 0.5,
      "severity": "none"
    },
    "cpic_guidelines": {
      "recommendation_level": "No data",
      "strength_of_recommendation": "Moderate",
      "clinical_guidance": "",
      "cpic_evidence": "No data",
      "reference": "Manual review required"
    },
    "pharmacogenomic_profile": {
      "primary_gene": "CYP2C19",
      "diplotype": "*1/*2",
      "phenotype": "IM",
      "detected_variants": [
        {
          "rsid": "rs3288976",
          "gene": "CYP2C19",
          "genotype": "*1/*2",
          "phenotype": "Intermediate Metabolizer"
        }
      ]
    },
    "clinical_recommendation": {
      "summary": "CYP2C9: No variant data available | VKORC1: No variant data available",
      "dosing": "Standard dosing",
      "monitoring": "Monitor for adverse effects; adjust if needed"
    },
    "llm_generated_explanation": {
      "summary": "Based on genetic profile, Warfarin shows unknown risk.",
      "clinical_impact": "CYP2C9: No variant data available | VKORC1: No variant data available"
    },
    "quality_metrics": {
      "vcf_parsing_success": true,
      "genes_analyzed": [
        "CYP2C19"
      ],
      "variant_count": 1,
      "data_completeness": "standard",
      "algorithm_version": "CPIC-aligned-v2"
    }
  },
  {
    "patient_id": "PATIENT_355BF81D",
    "drug": "Clopidogrel",
    "timestamp": "2026-02-19T16:51:46.711577",
    "risk_assessment": {
      "risk_label": "Adjust Dosage",
      "confidence_score": 0.95,
      "severity": "moderate"
    },
    "cpic_guidelines": {
      "recommendation_level": "2B",
      "strength_of_recommendation": "Moderate",
      "clinical_guidance": "Intermediate metabolizers have reduced antiplatelet effect; may not achieve therapeutic levels.",
      "cpic_evidence": "2B - Moderate",
      "reference": "CPIC Clopidogrel/CYP2C19 Guidelines"
    },
    "pharmacogenomic_profile": {
      "primary_gene": "CYP2C19",
      "diplotype": "*1/*2",
      "phenotype": "IM",
      "detected_variants": [
        {
          "rsid": "rs3288976",
          "gene": "CYP2C19",
          "genotype": "*1/*2",
          "phenotype": "Intermediate Metabolizer"
        }
      ]
    },
    "clinical_recommendation": {
      "summary": "Consider alternative P2Y12 inhibitor (prasugrel 5-10 mg daily or ticagrelor 60-90 mg daily) OR increase clopidogrel to 150 mg daily",
      "dosing": "200% increase (150 mg) if continuing clopidogrel% adjustment",
      "monitoring": "Assess antiplatelet response; platelet function testing helpful; higher stent thrombosis risk"
    },
    "llm_generated_explanation": {
      "summary": "Based on genetic profile, Clopidogrel shows adjust dosage risk.",
      "clinical_impact": "CYP2C19 (Intermediate Metabolizer): Adjust Dosage"
    },
    "quality_metrics": {
      "vcf_parsing_success": true,
      "genes_analyzed": [
        "CYP2C19"
      ],
      "variant_count": 1,
      "data_completeness": "standard",
      "algorithm_version": "CPIC-aligned-v2"
    }
  }
]